Antiproliferative and antimetastatic action of quercetin on A549 non-small cell lung cancer cells through its effect on the cytoskeleton

Acta Histochemica

Volumn 119, Issue 2, 2017, Pages 99-112

  Klimaszewska Wiśniewska, Anna ^a   Hałas Wiśniewska, Marta ^a   Izdebska, Magdalena ^a   Gagat, Maciej ^a   Grzanka, Alina ^a   Grzanka, Dariusz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Apoptosis; Cytoskeleton; Mitotic catastrophe; Non small cell lung cancer; Quercetin

Indexed keywords

BETA TUBULIN; F ACTIN; LIPOCORTIN 5; NERVE CELL ADHESION MOLECULE; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; QUERCETIN; VIMENTIN; ANTINEOPLASTIC AGENT; CYTOSKELETON PROTEIN; TUBULIN MODULATOR;

A-549 CELL LINE; ACTIN FILAMENT; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL MIGRATION ASSAY; CELL ULTRASTRUCTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINESIS; CYTOSKELETON; DNA CONTENT; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; FLUORESCENCE; HUMAN; HUMAN CELL; IC50; IN VITRO SCRATCH WOUND HEALING ASSAY; METASTASIS INHIBITION; METHYL THIAZOLYL TETRAZOLIUM ASSAY; MICROFILAMENT; MICROTUBULE; MIGRATION INHIBITION; MITOSIS; MITOSIS SPINDLE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAINING; TRANSMISSION ELECTRON MICROSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; DRUG SCREENING; LUNG NEOPLASMS; METABOLISM;

A549 CELLS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; CELL SURVIVAL; CYTOSKELETAL PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LUNG NEOPLASMS; MICROTUBULES; QUERCETIN; TUBULIN MODULATORS;

EID: 85006998819     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2016.11.003     Document Type: Article

References (64)

1. Arunakaran, J., Arunkumar, R., Elumalai, P., Senthilkumar, K., Impact of quercetin, diallyl disulfide and nimbolide on the regulation of nuclear factor kappa B expression in prostate and breast cancer cell lines. Nat. Prod. Chem. Res., 115, 2013, 1, 10.4172/2329-6836.1000115.
2. Böhl, M., Czupalla, C., Tokalov, S.V., Hoflack, B., Gutzeit, H.O., Identification of actin as quercetin-binding protein: an approach to identify target molecules for specific ligands. Anal. Biochem. 346 (2005), 295–299.
3. Böhl, M., Tietze, S., Sokoll, A., Madathil, S., Pfennig, F., Apostolakis, J., Fahmy, K., Gutzeit, H.O., Flavonoids affect actin functions in cytoplasm and nucleus. Biophys. J. 93 (2007), 2767–2780.
4. Caltagirone, S., Rossi, C., Poggi, A., Ranelletti, F.O., Natali, P.G., Brunetti, M., Aiello, F.B., Piantelli, M., Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int. J. Cancer 87 (2000), 595–600.
5. Chapman, R.S., Chresta, C.M., Herbergm, A.A., Beere, H.M., Heer, S., Whetton, A.D., Hickman, J.A., Dive, C., Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells. Cytometry 20 (1995), 245–256.
6. Chou, T.C., Martin, N., CompuSyn Software for Drug Combinations and for General Dose-effect Analysis, and User's Guide. 2007, ComboSyn Inc, Paramus NJ.
7. Chou, T.C., Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58 (2006), 621–681.
8. Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T., Traganos, F., Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27 (1997), 1–20.
9. Dauphin, M., Barbe, C., Lemaire, S., Nawrocki-Raby, B., Lagonotte, E., Delepine, G., Birembaut, P., Gilles, C., Polette, M., Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas. Lung Cancer 81 (2013), 117–122.
10. Desouza, M., Gunning, P.W., Stehn, J.R., The actin cytoskeleton as a sensor and mediator of apoptosis. Bioarchitecture 2 (2012), 75–87.
11. Duo, J., Ying, G.G., Wang, G.W., Zhang, L., Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via BCL2 and BAX regulation. Mol. Med. Rep. 5 (2012), 1453–1456.
12. Farooqui, R., Fenteany, G., Multiple rows of cells behind an epithelial wound edge extend cryptic lamellipodia to collectively drive cell-sheet movement. J. Cell Sci. 118 (2005), 51–63.
13. Fawzy, G.A., Al-Taweel, A.M., Perveen, S., Anticancer activity of flavane gallates isolated from Plicosepalus curviflorus. Pharmacogn. Mag. 3 (2014), 519–523.
14. Firdous, A.B., Sharmila, G., Balakrishnan, S., RajaSingh, P., Suganya, S., Srinivasan, N., Arunakaran, J., Quercetin, a natural dietary flavonoid, acts as a chemopreventive agent against prostate cancer in an in vivo model by inhibiting the EGFR signaling pathway. Food Funct. 5 (2014), 2632–2645.
15. Gagat, M., Grzanka, D., Izdebska, M., Mączyńska, E., Grzanka, A., Nornicotine impairs endothelial cell-cell adherens junction complexes in EA.hy926 cell line via structural reorganization of F-actin. Folia Histochem. Cytobiol. 51 (2013), 179–192.
16. Galluzzi, L., Vitale, I., Abrams, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19 (2012), 107–120.
17. Ganguly, A., Yang, H., Sharma, R., Patel, K.D., Cabral, F., The role of microtubules and their dynamics in cell migration. J. Biol. Chem. 287 (2012), 43359–43369.
18. Garg, A.K., Buchholz, T.A., Aggarwal, B.B., Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal. 12 (2005), 1630–1647.
19. Grzanka, A., Grzanka, D., Orlikowska, M., Cytoskeletal reorganization during process of apoptosis induced by cytostatic drugs in K-562 and HL-60 leukemia cell lines. Biochem. Pharmacol. 66 (2003), 1611–1617.
20. Gupta, K., Panda, D., Perturbation of microtubule polymerization by quercetin through tubulin binding:a novel mechanism of its antiproliferative activity. Biochemistry 41 (2002), 13029–13038.
21. Hałas, M., Izdebska, M., Klimaszewska-Wiśniewska, A., Gagat, M., Radciniewska, D., Glińska, A., Gizler, K., Bielińska, E., Grzanka, A., Caffeine induces cytoskeletal changes and cell death in H1299 cells. Cent. Eur. J. Biol. 9 (2014), 727–738.
22. Haddad, A.Q., Venkateswaran, V., Viswanathan, L., Teahan, S.J., Fleshner, N.E., Klotz, L.H., Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis. 9 (2006), 68–76.
23. Havel, L.S., Kline, E.R., Salgueiro, A.M., Marcus, A.I., Vimentin regulates lung cancer cell adhesion through a VAV2-RAC1 pathway to control focal adhesion kinase activity. Oncogene 34 (2015), 1979–1990.
24. Heng, Y.W., Koh, C.G., Actin cytoskeleton dynamics and the cell division cycle. Int. J. Biochem. Cell Biol. 42 (2010), 1622–1633.
25. Huang, X., Halicka, H.D., Traganos, F., Tanaka, T., Kurose, A., Darzynkiewicz, Z., Cytometric assessment of DNA damage in relation to cell-cycle phase and apoptosis. Cell Prolif. 38 (2005), 223–243.
26. Iwazaki, R., Watanabe, S., Otaka, K., Ota, K., Ono, Y., Sato, N., The role of the cytoskeleton in migration and proliferation of a cultured human gastric cancer cell line using a new metastasis model. Cancer Lett. 119 (1997), 191–199.
27. Jackson, S.J.T., Venema, R.C., Quercetin inhibits eNOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells. J. Nutr. 136 (2006), 1178–1184.
28. Jordan, M.A., Wilson, L., Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 10 (1998), 123–130.
29. Jordan, M.A., Wilson, L., Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4 (2004), 253–265.
30. Karna, P., Rida, P.C., Pannu, V., Gupta, K.K., Dalton, W.B., Joshi, H., Yang, V.W., Zhou, J., Aneja, R., A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering. Cell Death Differ. 18 (2011), 632–644.
31. Kim, W.K., Bang, M.H., Kim, E.S., Kang, N.E., Jung, K.C., Cho, H.J., et al. Quercetin decreases the expression of ERBB2 and ERBB3 proteins in HT-29 human colon cancer cells. J. Nutr. Biochem. 16 (2005), 155–162.
32. Klimaszewska-Wiśniewska, A., Hałas-Wiśniewska, M., Tadrowski, T., Gagat, M., Grzanka, D., Grzanka, A., Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells. Cancer Cell Int., 16, 2016, 10.
33. Korsmeyer, S.J., Shutter, J.R., Veis, D.J., Merry, D.E., Oltvai, Z.N., Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4 (1993), 327–332.
34. Lahat, G., Zhu, Q.S., Huang, K.L., Wang, S., Bolshakov, S., Liu, J., et al. Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mouse xenograft studies. PLoS One, 5, 2010, e10105, 10.1371/journal.pone.0010105.
35. Lin, Y.S., Tsai, P.H., Kandaswami, C.C., Cheng, C.H., Ke, F.C., Lee, P.P., Hwang, J.J., Lee, M.T., Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells. Cancer Sci. 102 (2011), 1829–1839.
36. Lin, C., Song, H., Huang, C., Yao, E., Gacayan, R., Xu, S.M., et al. Alveolar type II cells possess the capability of initiating lung tumor development. PLoS One, 7, 2012, e53817, 10.1371/journal.pone.0053817.
37. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001), 402–408.
38. Mc Gee, M.M., Targeting the mitotic catastrophe signaling pathway in cancer. Mediat. Inflamm. 2015 (2015), 1–13.
39. Mukherjee, A., Khuda-Bukhsh, A.R., Quercetin down-regulates IL6/STAT-3 signals to induce mitochondrial-mediated apoptosis in a nonsmall- cell lung-cancer cell line, A549. J. Pharmacopuncture 18 (2015), 19–26.
40. Nguyen, T.T., Tran, E., Nguyen, T.H., Do, P.T., Huynh, T.H., Huynh, H., The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 25 (2004), 647–659.
41. Notas, G., Nifli, A.P., Kampa, M., Pelekanou, V., Alexaki, V.I., Theodoropoulos, P., Vercauteren, J., Castanas, E., Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells. J. Nutr. Biochem. 23 (2012), 656–666.
42. Oberhammer, F., Wilson, J.M., Dive, C., Morris, I.D., Hickman, J.A., Wakeling, A.E., Walker, P.R., Sikorska, M., Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of intenucleosomal fragmentation. EMBO J. 12 (1993), 3679–3684.
43. Peng, P.L., Hsieh, Y.S., Wang, C.J., Hsu, J.L., Chou, F.P., Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol. Appl. Pharmacol. 214 (2006), 8–15.
44. Psahoulia, F.H., Drosopoulos, K.G., Doubravska, L., Andera, L., Pintzas, A., Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol. Cancer Ther. 6 (2007), 2591–2599.
45. Rodriguez, L.G., Wu, X., Guan, J.L., Wound-healing assay. Methods Mol. Biol. 294 (2005), 23–29.
46. Sak, K., Chemotherapy and dietary phytochemical agents. Chemother. Res. Pract. 2012 (2012), 1–11.
47. Sak, K., Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn. Rev. 8 (2014), 122–146.
48. Satelli, A., Li, S., Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci. 68 (2011), 3033–3046.
49. Saxena, A., Viswanathan, S., Moshynska, O., Tandon, P., Sankaran, K., Sheridan, D.P., Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia. Am. J. Hematol. 75 (2004), 22–33.
50. Senthilkumar, K., Arunkumar, R., Elumalai, P., Sharmila, G., Gunadharini, D.N., Banudevi, S., Krishnamoorthy, G., Benson, C.S., Arunakaran, J., Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem. Funct. 29 (2011), 87–95.
51. Shia, C.S., Suresh, G., Hou, Y.C., Lin, Y.C., Chao, P.D., Juang, S.H., Suppression on metastasis by rhubarb through modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: an ex vivo approach. J. Ethnopharmacol. 133 (2011), 426–433.
52. Sonoki, H., Sato, T., Endo, S., Matsunaga, T., Yamaguchi, M., Yamazaki, Y., Sugatani, J., Ikari, A., Quercetin decreases claudin-2 expression mediated by up-regulation of microRNA miR-16 in lung adenocarcinoma A549 cells. Nutrients 7 (2015), 4578–4592.
53. Srinivasan, A., Thangavel, C., Liu, Y., Shoyele, S., Den, R.B., Selvakumar, P., Lakshmikuttyamma, A., Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer. Mol. Carcinog. 55 (2016), 743–756, 10.1002/mc.22318.
54. Sun, B.O., Fang, Y., Li, Z., Chen, Z., Xiang, J., Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression. Biomed. Rep. 3 (2015), 603–610.
55. Surh, Y.J., Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 (2003), 768–780.
56. Takagi, T., Takekoshi, S., Okabe, T., Nagata, H., Honma, T., Watanabe, K., Quercetin, a flavonol, promotes disassembly of microtubules in prostate cancer cells: possible mechanism of its antitumor activity. Acta Histochem. Cytochem. 5 (1998), 435–445.
57. Tao, D., Wu, J., Feng, Y., Qin, J., Hu, J., Gong, J., New method for the analysis of cell cycle-specific apoptosis. Cytometry A 57 (2004), 70–74.
58. Thaiparambil, J.T., Bender, L., Ganesh, T., Kline, E., Patel, P., Liu, Y., Tighiouart, M., Vertino, P.M., Harvey, R.D., Garcia, A., Marcus, A.I., Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int. J. Cancer 129 (2011), 2744–2755.
59. Trendowski, M., Wong, V., Zoino, J.N., Christen, T.D., Gadeberg, L., Sansky, M., Fondy, T.P., Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle growth control parameters to induce sensitivity to low frequency ultrasound. Cancer Lett. 360 (2015), 160–170.
60. Trendowski, M., Exploiting the cytoskeletal filaments of neoplastic cells to potentiate a novel therapeutic approach. Biochim. Biophys. Acta 1846 (2014), 599–616.
61. Uphoff, C.C., Brauer, S., Grunicke, D., Gignac, S.M., MacLeod, R.A., Quentmeier, H., Steube, K., Tummler, M., Voges, M., Wagner, B., Sensitivity and specificity of five different mycoplasma detection assays. Leukemia 6 (1992), 335–341.
62. Yamazaki, D., Kurisu, S., Takenawa, T., Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96 (2005), 379–386.
63. Zhang, X., Liu, G., Kang, Y., Dong, Z., Qian, Q., Ma, X., N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines. PLoS One, 8, 2013, e57692, 10.1371/journal.pone.0057692.
64. Zhu, J., Beattie, E.C., Yang, Y., Wang, H.J., Seo, J.Y., Yang, L.X., Centrosome impairments and consequent cytokinesis defects are possible mechanisms of taxane drugs. Anticancer Res. 25 (2005), 1919–1925.